Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

342
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
342
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

6.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K
Paracrine Signaling01:21

Paracrine Signaling

59.3K
Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
59.3K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated plasma cholesterol improves sepsis outcome by promoting hepatic metabolic reprogramming.

Frontiers in immunology·2026
Same author

Identification of scavenger receptor BI as a scavenger of free heme that is essential for protection against hemolysis.

bioRxiv : the preprint server for biology·2026
Same author

Elevated plasma cholesterol causally improves sepsis outcome by promoting hepatic metabolic reprogramming.

bioRxiv : the preprint server for biology·2025
Same author

The Role of SR-BI in sepsis: leveraging mechanistic insights to advance precision steroid therapy.

Frontiers in immunology·2025
Same author

The ACTH test fails to diagnose adrenal insufficiency and augments cytokine production in sepsis.

JCI insight·2025
Same author

The Role of Scavenger Receptor BI in Sepsis.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Jan 10, 2026

Imaging Ca2+ Signals in Small Pulmonary Veins at Physiological Intraluminal Pressures
05:35

Imaging Ca2+ Signals in Small Pulmonary Veins at Physiological Intraluminal Pressures

Published on: March 21, 2025

705

Nitric oxide, caveolae, and vascular pathology.

Xiang-An Li1, William Everson, Eric J Smart

  • 1Department of Pediatrics, University of Kentucky Medical School, Lexington, 40536, USA.

Cardiovascular Toxicology
|July 18, 2006
PubMed
Summary

Endothelial nitric oxide synthase (eNOS) regulates cardiovascular function. This review explores how cardiovascular disease factors and drugs alter eNOS activity via caveolae, impacting heart health.

Area of Science:

  • Cardiovascular Biology
  • Cellular Signaling
  • Pharmacology

Background:

  • Endothelial nitric oxide synthase (eNOS) is vital for cardiovascular health.
  • Caveolae are cellular structures regulating signaling pathways, including nitric oxide.
  • Cardiovascular diseases involve altered eNOS activity and caveolae function.

Purpose of the Study:

  • To review the regulation of eNOS activity by circulating factors in cardiovascular disease.
  • To examine the impact of pharmacological interventions on eNOS activity through caveolae.
  • To elucidate mechanisms linking cardiovascular disease, eNOS, and caveolae.

Main Methods:

  • Literature review of studies on eNOS, caveolae, and cardiovascular disease.
  • Analysis of research on circulating factors affecting eNOS.

More Related Videos

Development and Characterization of In Vitro Microvessel Network and Quantitative Measurements of Endothelial [Ca2+]i and Nitric Oxide Production
09:39

Development and Characterization of In Vitro Microvessel Network and Quantitative Measurements of Endothelial [Ca2+]i and Nitric Oxide Production

Published on: May 19, 2016

9.0K
En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

10.0K

Related Experiment Videos

Last Updated: Jan 10, 2026

Imaging Ca2+ Signals in Small Pulmonary Veins at Physiological Intraluminal Pressures
05:35

Imaging Ca2+ Signals in Small Pulmonary Veins at Physiological Intraluminal Pressures

Published on: March 21, 2025

705
Development and Characterization of In Vitro Microvessel Network and Quantitative Measurements of Endothelial [Ca2+]i and Nitric Oxide Production
09:39

Development and Characterization of In Vitro Microvessel Network and Quantitative Measurements of Endothelial [Ca2+]i and Nitric Oxide Production

Published on: May 19, 2016

9.0K
En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

10.0K
  • Examination of pharmacological agents influencing eNOS via caveolae.

    • Main Results:

    • Cardiovascular disease alters circulating factors that modulate eNOS activity.
    • Pharmacological interventions can restore eNOS function by targeting caveolae.
    • eNOS activity is intricately regulated by caveolae-associated proteins.

    Conclusions:

    • Understanding eNOS regulation in cardiovascular disease is crucial for therapeutic development.
    • Targeting caveolae offers a potential strategy for modulating eNOS activity.
    • Further research is needed to fully elucidate the eNOS-caveolae interaction in cardiovascular health and disease.